Mann, J. F. E. Et Al. 2008. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. LANCET , vol.372, no.9638 , 547-553.

Mann, J. F. E., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., ... Wang, X.(2008). Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. LANCET , vol.372, no.9638, 547-553.

Mann, Johannes Et Al. "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial," LANCET , vol.372, no.9638, 547-553, 2008

Mann, Johannes F. Et Al. "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial." LANCET , vol.372, no.9638, pp.547-553, 2008

Mann, J. F. E. Et Al. (2008) . "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial." LANCET , vol.372, no.9638, pp.547-553.

@article{article, author={Johannes F. E. Mann Et Al. }, title={Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial}, journal={LANCET}, year=2008, pages={547-553} }